ARTICLES BY THIS AUTHOR
- 9/15/2022
FDA gives AstraZeneca approval for Imfinzi
Imfinzi is used to treat adult patients with locally advanced or metastatic biliary tract cancer in combination with chemotherapy (gemcitabine plus cisplatin). - 9/15/2022
BJ’s Wholesale Club to accept online SNAP EBT payments chainwide
When using its SNAP EBT cards to shop online at BJs.com or on the BJ’s mobile app, members have the option of selecting from multiple delivery methods, including free pickup, shipping and same-day delivery. - 9/15/2022
Rite Aid kicks off family immunization days
Routine vaccinations and immunizations are available at select Rite Aid and Bartell Drugs locations on weekdays after work and on the weekends. - 9/15/2022
Kroger expands delivery to Birmingham, Ala.
Kroger opened a new spoke facility serving the southern region, and it expects to employ more than 160 new associates. - 9/14/2022
Amazon intros free email marketing capabilities for sellers
Utilizing Amazon Customer Engagement’s Tailored Audiences, sellers can now increase their email marketing reach and build brand loyalty, the company said. - 9/14/2022
Dr. Scholl’s debuts Instant Cool Athlete’s Foot solutions
Dr. Scholl’s is working with former head football coach and analyst Rex Ryan and surgeon Brad Schaeffer of TLC’s “My Feet Are Killing Me” on the launch of its Instant Cool Athlete’s Foot solutions. - 9/14/2022
Xiromed launches generic Faslodex
Generic Faslodex is used to treat advanced-stage, hormone receptor-positive, HER2-negative breast cancer. - 9/13/2022
FDA approves Boehringer Ingelheim’s Spevigo
Spevigo is the first approved treatment option for generalized pustular psoriasis flares in adults. - 9/13/2022
CVS Health completes rollout of time-delay safes in 3 southern states
All 213 CVS Pharmacy locations across Louisiana, Mississippi and Arkansas are now using time-delay safe technology. - 9/13/2022
NACDS Foundation opens community impact project proposals
The foundation has released a request for proposals opportunity to award up to $1.5 million in new research.